| Property | Value |
|---|
|
?:abstract
|
-
There is great concern about the impact of COVID-19 among the nearly 40 million people living with HIV (PLWH) worldwide In this review, we surveyed current literature and found no evidence of higher prevalence of COVID-19 among PLWH but equivocal data on increased mortality and worse clinical outcomes Having HIV does not confer protection against severe manifestations of COVID-19 Several studies looking at antiretroviral drugs against HIV to treat SARS-CoV-2 have shown no mortality benefit Thus, there is no indication to change ART regimens among virologically suppressed PLWH to prevent COVID-19 HIV care delivery has been adversely impacted in several countries during this pandemic but has created an opportunity for accelerating effective strategies like multi-month ART Decentralizing HIV care in low-resource settings and incorporating telemedicine in high-resource settings will be critical in mitigating shocks to healthcare systems in the future
|
|
is
?:annotates
of
|
|
|
?:creator
|
|
|
?:journal
|
-
Journal_of_Virus_Eradication
|
|
?:license
|
|
|
?:publication_isRelatedTo_Disease
|
|
|
is
?:relation_isRelatedTo_publication
of
|
|
|
?:source
|
|
|
?:title
|
-
Impact of COVID-19 on people with HIV: A Review
|
|
?:type
|
|
|
?:who_covidence_id
|
|
|
?:year
|
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}